NCT07168551Not yet recruiting
Is There a Relationship Between Uric Acid Level and Liver Fibrosis in Obese Patients
Association of Hyperuricemia and Non Alcoholic Fatty Liver Disease and Liver Fibrosis Risk in Adult Obese Patients
Source: ClinicalTrials.gov · Last updated 15 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
1. Identifying the association between hyperuricemia and NAFLD can lead to early detection and prevention of liver fibrosis in adult obese patients. 2. Understanding the relationship between hyperuricemia and NAFLD can inform targeted therapy, such as urate-lowering treatment, to potentially slow disease progression. 3 - To examine the relationship between serum uric acid levels and liver fibrosis severity\*: Assessing the correlation between serum uric acid levels and the severity of liver fibrosis in adult obese patients with NAFLD. 4- To identify potential mechanisms underlying the association\*: Exploring the potential mechanisms by which hyperuricemia may contribute to the development and progression of NAFLD and liver fibrosis in adult obese patients.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 111 (estimated)
- First submitted
- 27 Aug 2025
- Start date
- 1 Oct 2025
- Primary completion date
- 1 Oct 2026
- Lead sponsor
- Assiut University
- Diseases
- Obesity, Fatty liver disease (MASLD/MASH)
- NCT number
- NCT07168551
What you commit to
- Study type: Observational
- Planned participants: 111
- From 1 Oct 2025 to the primary completion date, 1 Oct 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- excessive alcohol consumption ( \> 20 gm /day in men and 10 in g /day in women )
- 2- use of steatogenic within the past 6 months
- 3- positive test for hepatitis B surface antigen and hepatitis B core antibody
- 4- Drug induced liver injury and autoimmune hepatitis
- 5 - cirrhosis and other causes of liver disease
Who the study is looking for
- Age: Adults (typically 18-65 years old)
- 2 - Body Mass Index (BMI): Obese patients with a BMI ≥ 30 kg/m²
- 3- Hyperuricemia : Elevated serum uric acid levels (typically \> 7 mg/dL for men and \> 6 mg/dL for women)
Age in the registry: 18 years to 65 years · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.